Omeprazole
DrugBank ID: DB00338
Summary
| Metric | Value |
|---|---|
| Total Predictions | 51 |
| KG+DL (Dual Validated) | 8 |
| DL Only | 42 |
| KG Only | 1 |
Predictions
| Indication | Score | Source |
|---|---|---|
| duodenogastric reflux | 0.9964 | DL |
| duodenal obstruction | 0.9964 | DL |
| duodenal ulcer (disease) | 0.9959 | KG+DL |
| gastrin secretion abnormality | 0.9934 | KG+DL |
| active peptic ulcer disease | 0.9881 | DL |
| peptic esophagitis | 0.9877 | KG+DL |
| gastric ulcer (disease) | 0.9852 | KG+DL |
| gastrojejunal ulcer | 0.9851 | DL |
| peptic ulcer perforation | 0.9851 | DL |
| Zollinger-Ellison syndrome | 0.9785 | KG+DL |
| abnormality of glucagon secretion | 0.9704 | DL |
| gastroduodenitis | 0.9666 | DL |
| esophagitis (disease) | 0.9662 | KG+DL |
| Smouldering systemic mastocytosis | 0.9647 | DL |
| lymphoadenopathic mastocytosis with eosinophilia | 0.9573 | DL |
| duodenitis | 0.9524 | DL |
| leather-bottle stomach | 0.9514 | DL |
| peptic ulcer disease | 0.9462 | KG+DL |
| multiple endocrine neoplasia | 0.9445 | DL |
| systemic mastocytosis | 0.9435 | DL |
| nephrogenic syndrome of inappropriate antidiuresis | 0.9195 | DL |
| acne (disease) | 0.9136 | DL |
| pancreas disease | 0.8257 | DL |
| malaria | 0.8070 | DL |
| achlorhydria | 0.8048 | DL |
| hiatus hernia (disease) | 0.7916 | DL |
| Dieulafoy lesion | 0.7698 | DL |
| cascade stomach | 0.7698 | DL |
| gastric dilatation | 0.7698 | DL |
| pylorospasm | 0.7698 | DL |
| hemorrhagic duodenitis | 0.7522 | DL |
| hyperinsulinism (disease) | 0.6981 | KG+DL |
| intraepithelial neoplasia | 0.6664 | DL |
| acrogeria | 0.6647 | DL |
| nephrogenic diabetes insipidus | 0.6319 | DL |
| oral mucosa leukoplakia | 0.6123 | DL |
| diphtheritic myocarditis | 0.5935 | DL |
| secondary short bowel syndrome | 0.5925 | DL |
| afferent loop syndrome | 0.5796 | DL |
| trichostrongylosis | 0.5749 | DL |
| scleral staphyloma (disease) | 0.5685 | DL |
| Wiskott-Aldrich syndrome 2 | 0.5667 | DL |
| Coronavinae infectious disease | 0.5659 | DL |
| cholangiocarcinoma, susceptibility to | 0.5599 | DL |
| arteriosclerosis obliterans | 0.5583 | DL |
| entropion (disease) | 0.5581 | DL |
| astigmatism (disease) | 0.5573 | DL |
| lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis | 0.5562 | DL |
| anuria | 0.5540 | DL |
| toxic labyrinthitis | 0.5534 | DL |
Showing top 50 of 51 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.